Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How are they able to file bankruptcy but not include there primary asset...Cetera?
Very well!
Learn Why Turlov Timur R Just Opened Huge Bmb Munai Inc Position
Read more: www.octafinance.com/learn-why-turlov-timur-r-just-opened-huge-bmb-munai-inc-position/
Turlov Timur R New Position in BMB Munai Inc. (OTCMKTS:BMBM)
Turlov Timur R has filled a SC 13D form regarding Bmb Munai Inc . Filing Link: 000103883815000185. Per Turlov Timur R’s filing, the filler now owns 80.1% of the Energy-company, holding 224,551,913 shares.
BMB Munai Inc. (OTCMKTS:BMBM) is a newly disclosed equity position and the filing was required due to activity on November 23, 2015. This most probably shows Turlov Timur R’s confidence and optimism in the future of the company.
Why Turlov Timur R Bought Bmb Munai Inc
Item 4.Purpose of Transaction
The information contained on the cover pages to this Schedule 13D and the information set forth in Items 3, 5 and 6 hereof are incorporated by reference herein.
Section 1.2 of the Acquisition Agreement provides that Mr. Turlov may acquire up to an additional 13% of the then total issued and outstanding common stock of the Issuer in exchange for all of the issued and outstanding common stock of Freedom RU, including its wholly owned subsidiary, Freedom KZ.If the Freedom RU closing is completed, Mr. Turlov would own 93% of the then total issued and outstanding common stock of the Issuer and Freedom RU would become a wholly owned subsidiary of the Issuer.The Acquisition Agreement provides further that Mr. Turlov may acquire up to an additional 2% of the then total issued and outstanding common stock of the Issuer in exchange for all of the issued and outstanding common stock of Freedom CY and Freedom CY would become a wholly owned subsidiary of the Issuer.If the Freedom RU and the Freedom CY closings are successfully completed, Mr. Turlov would own 95% of the then total issued and outstanding common stock of the Issuer.Closing of the acquisitions of Freedom RU and Freedom CY is subject to satisfaction of the terms and conditions of the Article 1, Plan of Exchange; Closings, Article 2 Conditions Precedent to the Company’s Obligation to Close and Article 3 Conditions Precedent to Shareholder’s Obligation to Close of the Acquisition Agreement.If the Issuer is successful in closing the acquisitions of Freedom RU and Freedom CY, Mr. Turlov will own 95% of the then issued and outstanding common stock of the Issuer.
From time to time FFIN or the Issuer may require additional operating capital to satisfy their operating or net capital requirements.If Mr. Turlov infuses additional capital into FFIN or the Issuer, he may be issued additional shares of the Issuer.Mr. Turlov has no agreement with the Issuer regarding any additional capital infusions and is under no obligation, contractual or otherwise to provide additional capital to the Issuer or FFIN.
As a result of the FFIN closing, Mr. Turlov became the Issuer’s largest shareholder, and FFIN became a wholly owned subsidiary of the Issuer.The Issuer’s ongoing operations will consist of the continuation of FFIN’s business and, subject to successfully closing the acquisitions of Freedom RU and Freedom CY, as discussed herein, the continuation of their business activities as well.The Acquisition Agreement is being treated as a reverse acquisition of the Issuer, a public shell company, for financial accounting and reporting purposes. As such, FFIN is treated as the acquirer for accounting and financial reporting purposes and the subsequent closings of Freedom RU and Freedom CY will be treated as acquisitions of entities under common control for accounting and financial reporting purposes. As a result, the historical financial statements reflected in the Issuer’s future financial statements will be those of FFIN, and following the subsequent closings, if successful, will include Freedom RU and Freedom CY. The Issuer’s assets, liabilities, and results of operations will be consolidated with the assets, liabilities, and results of operations of FFIN, and following the subsequent closings, if successful, will include Freedom RU and Freedom CY.
As disclosed in the Current Report on Form 8-K of the Issuer filed with the Securities and Exchange Commission (the “Commission”) on November 23, 2015, in connection with the FFIN closing, Boris Cherdabayev and Valery Tolkachev resigned as directors, and Mr. Turlov was appointed as chairman and Arkady Rakhilkin, Mr. Turlov’s designee, was appointed to the Issuer’s board of directors, joining its incumbent directors Askar Tashtitov, Jason Kerr, and Leonard Stillman. Mr. Tashtitov resigned as the Issuer’s president. The new board appointed Mr. Turlov as chief executive officer.The other officers of the Issuer remain unchanged.
Pursuant to Section 1.3(b)(ii) of the Acquisition Agreement, at such time as the Issuer may deem appropriate, it shall submit to its stockholders for consideration, with the recommendation of its board of directors that the stockholders approve, a recapitalization of its currently authorized shares of common stock and an increase to the number of its authorized post-reverse-split shares of common stock in such amounts as the board of directors may then determine (the “Recapitalization”) to assure that the Issuer has a sufficient number of authorized but unissued shares to effect the FreedomRU Closing or the FreedomCY Closing, as the case may be, contemplated in the Acquisition Agreement and to continue its activities. In order to obtain this approval, the Issuer shall submit the Recapitalization for consideration by its stockholders in accordance with its articles of incorporation, bylaws, and applicable law, either by majority written consent followed by required notice of action to its stockholders or at a duly constituted special or annual meeting of stockholders, in each case subject to satisfying the proxy or consent solicitation provisions of Section 14 of the Exchange Act and the regulations promulgated thereunder.
Except as disclosed in this Schedule 13D or in the Acquisition Agreement, Mr. Turlov has no present plans or proposals that would relate to or result in the occurrence of any of the matters set forth in subparagraphs (a)-(j)of Item4 of Schedule 13D.Mr. Turlov intends to review his investment in the Issuer on a continuing basis and may in the future engage in discussions with management, the board of directors, other stockholders and other relevant parties concerning the business, operations, board composition, management, strategy and future plans of the Issuer. Depending on various factors including, without limitation, the results of the Issuer’s financial position and business strategy, price levels of the common stock, conditions in the securities market and general economic and industry conditions, Mr. Turlov may in the future take such actions with respect to his investment in the Issuer as he deems appropriate including, without limitation, purchasing additional shares or selling some or all of his shares, engaging in any hedging or similar transactions with respect to his shares, engaging in discussions with management, the board of directors, other stockholders and other relevant parties concerning the business, operations, board composition, management, strategy and future performance of the Issuer or taking other action to effect changes in the board composition, ownership structure or operations of the Issuer, encouraging the Issuer to pursue one or more strategic transactions and/or otherwise changing his intention with respect to any and all matters referred to in Item4 of Schedule 13D.
I agree, this will no doubt get interesting...and I am glad to be holding shares, especially as the float continues to decrease.
Drugdoctor either wants our shares or can't read...either way, he/she is not getting my shares either.
Just slapped it for 61k...thanks for selling.
Yeah, I registered their last week and yet to receive an email...hmmmm
I registered my email w/ them on their website a week ago when I did my initial purchase...
I'm interested to know how some received a shareholder letter (e-mail) and not others. Fore example, I did not receive an email....and yes, I am a shareholder.
Hmmmm...
What's not to like about the potential of BMBM?? Def holding here!
www.otcmarkets.com/edgar/GetFilingPdf?FilingID=11031070
www.otcmarkets.com/edgar/GetFilingPdf?FilingID=11043453
Slapped the ask yesterday and averaged down...definitely moving forward from here.
That answers my next question...the latest 10Q had restricted shares issued with values of $1.20 and others of .041. Thanks for sharing
Got it, restricted shares is better, the response from the TA to me did not include the Float and therefore had to assume...
Smitter, appreciate the reply but this company is diluting...4mil since the 3rd and like you said their has been pretty low volume. I now no longer have any intentions of purchasing more of this company, their CFO blatantly lied in that email you stickied....dilution is dilution no matter how you shake it...after all the DD that is posted on this board, available PRs, and filings - one would think there would be NO reason to dilute....disappointing.
Anybody get updated share count from TA? Interested in averaging down but slightly concerned...
Agree, but it will fill the gap @ .27...
Needs to recede and fill gap...
OS vs AS not worth the risk IMHO...
I agree with you zj3001...think some are just trying to get the price down for a better entry point.
My take on HTIC: know what you own and be patient, our time will come.
Know what you own and be patient...our time will most certainly come.
This is going right past the 200MA in a few days...then into the Blue unknown. Keep it on the down low Carlos!
Just my opinion, but in all the reading and links available (to include FORBES!!), there is no way Timur Turlov intends on BMBM to remain on the OTC.
Hope Simon Chin has info other than this...and if so, pony up...
T 1285/10 (Genetic analysis computing system/IRIS BIOTECHNOLOGIES)
< www.epo.org/law-practice/case-law-appeals/recent/t101285eu1.html >
European Case Law Identifier: ECLI:EP:BA:2014:T128510.20140523
Summary of Facts and Submissions
I. The appeal is against the decision of the examining division, posted 15 January 2010, to refuse European patent application No. 00 957 869.1. The decision was based on the grounds of added subject-matter
(Article 123(2) EPC) and lack of clarity
Here again, the board is not convinced. The system of D3 does not simply compare indicators with thresholds but uses a correlation between a plurality of indicators and a plurality of diseases to provide a diagnosis, and relies on personal factors to provide a medical treatment (see for instance page 2, lines 5 to 33). Even if it can be assumed that a genetic database comprises a much larger number of parameters than the database of D3, the implementation of such a database in the system of D3 does not require any inventive skill for a computer specialist.
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance for further prosecution.
Wonder what happened to the European patent he was to receive on Dec 9th?
Agree, under the radar is nice...at this rate, pretty soon anything under a nickel is gold.
Awesome, thanks for sharing
Awesome, thanks for sharing all the outstanding DD you are doing Nikita. BRBM is still largely under the radar and definately a good thing for us as this has all the potential to be an amazing stock...think I may purchase more before the party starts, cuz there is definately going to be plenty here at some point.
Solid DD, thanks
I'm in...No Dilution per 13d
http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=11043453
is it that time again??
This is holding up beautifully...next week will be legendary as the anticipated patent PR should fly on or about Dec 9 according to the latest PR. IRSB
Welcome back...nice size bid there
Congrats and best of luck to you!
I agree with the $2+ valuation and unfortunately won't be selling any shares to you...but I am sure somebody looking to cash out on a Friday may (would be smarter to hold though based on the December 9th patent and almost guaranteed Press Release announcing it). That is when this will kick into 2nd gear cuz I think we are still in 1st and ripping it up to dollar land.
My opinion for you: "A bird in the hand is worth more than 2 in the bush"
Whoa!! 250k bid @ .36